Tamer I. Khayal - 20 Feb 2023 Form 4 Insider Report for TransMedics Group, Inc. (TMDX)

Role: Chief Commercial Officer
Signature: By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol: TMDX
Transactions as of: 20 Feb 2023
Net transactions value: $0
Form type: 4
Filing time: 22 Feb 2023, 19:00:56 UTC
Previous filing: 16 Feb 2023
Next filing: 27 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMDX	Common Stock	Award	$0	+13,075	+1006%	$0.000000	14,375	20 Feb 2023	Direct	F1
holding	TMDX	Common Stock						11,051	20 Feb 2023	By the Tamer Ibrahim Ahmed Khayal Trust
holding	TMDX	Common Stock						24,776	20 Feb 2023	By the Khayal Family 2021 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TMDX	Stock Option (Right to Buy)	Award	$0	+20,022		$0.000000	20,022	20 Feb 2023	Common Stock	20,022	$66.10	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 13,075 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2	The option vests at a rate of 2.0833% of the total number of shares subject to the option each month following February 20, 2023 until the option is fully vested on February 20, 2027, subject to continued service.